Mining Bugs for Drugs
The Bio Report - En podcast af Levine Media Group - Onsdage
Kategorier:
Ross Youngs, CEO and founder of Biosortia Microbiomics, discusses the case for exploring various microbiomes to discover new small molecule drugs, how the company’s platform technology enables it to investigate a much broader range of microbes, and its business model for capitalizing on the discoveries it makes.
